Individualizing Heart Failure Treatment
Cardiology
Curriculum:
Recognizing and Managing Heart Failure in Primary Care
Recognizing and Managing Heart Failure in Primary Care
Credits:
1 AANP Contact Hours 1 AMA PRA Category 1 Credit(s) ™
1 AANP Contact Hours 1 AMA PRA Category 1 Credit(s) ™
Launch Date:
October 19, 2016
October 19, 2016
Expiration Date:
The accreditation for this activity has expired.
The accreditation for this activity has expired.
Primary Audience:
Primary Care MD/DO and NPs/PAs and other clinicians managing patients with Heart Failure
Relevant Terms:
Heart failure; racial disparities; heart rate; biomarkers
Barbara A. Hutchinson, MD, PhD, FACC
Barbara A. Hutchinson, MD, PhD, FACC
Managing Partner
Chespeake Cardiac Care
Annapolis, MD
Bio
Dr. Hutchinson is the managing partner of Chesapeake Cardiac Care, P.A., a cardiology practice located in Annapolis, Maryland. She is board certified in both cardiovascular disease and sleep medicine. Patients from all over the world seek her out, and she is a noted speaker on heart disease in women and how sleep affects heart health. Dr. Hutchinson is also an instructor in the Department of Internal Medicine at University of Maryland Hospital in Baltimore, Maryland.
Dr. Hutchinson is currently President of the Association of Black Cardiologists, and a Fellow of the American College of Cardiology (FACC). Additionally, Dr. Hutchinson is the recipient of numerous awards, including the Caribbean American Heritage Award, Innovator of the Year, Enterprising Woman of the Year, Impact Award, and Brava Award.
Anekwe Onwuanyi, MD, FACC, FAHA, FACP, FHFSA
Anekwe Onwuanyi, MD, FACC, FAHA, FACP, FHFSA
Professor of Medicine
Chief of Cardiology
Morehouse School of Medicine
Medical Director, Heart Failure Program
Grady Health System
Atlanta, GA
Bio
Anekwe E. Onwuanyi is currently Professor of Medicine and serves as Chief of Cardiology at Morehouse School of Medicine and Medical Director of the Heart Failure Program at Grady Memorial Hospital. He is board certified in Cardiovascular Diseases and Advanced Heart Failure and Transplant Cardiology. He is a consultant cardiologist at Grady Memorial Hospital, Wellstar Main and South Atlanta Medical Center and Emory Midtown Hospital in Atlanta, Georgia. Prior to joining Morehouse School of Medicine, Dr. Onwuanyi held faculty appointments as Assistant Professor of Medicine at Mount Sinai School of Medicine and Columbia University College of Physicians and Surgeons in New York.
In addition to his clinical activities and teaching responsibilities, Dr. Onwuanyi research interest includes heart failure, hypertension, coronary artery disease and evaluation of disparities in cardiovascular disease outcomes in the USA. He has participated as site Principal Investigator and Co-Investigator for several National Institute of Health supported research in the area of hypertension, congestive heart failure and atherosclerosis. Dr. Onwuanyi has published several papers in peer-reviewed journals.
| 1. | Know the risk factors for heart failure and the role of biomarkers in diagnosis and treatment | 2. | Recognize the importance of heart rate in cardiovascular risk of heart failure |
| 3. | Utilize the most recent clinical evidence to inform decisions for the management of heart failure | 4. | Identify approaches to facilitate early recognition and optimization of heart failure management |
| 1. | Know the risk factors for heart failure and the role of biomarkers in diagnosis and treatment |
| 2. | Recognize the importance of heart rate in cardiovascular risk of heart failure |
| 3. | Utilize the most recent clinical evidence to inform decisions for the management of heart failure |
| 4. | Identify approaches to facilitate early recognition and optimization of heart failure management |
Planning Committee
Gregg Sherman, MD
National Association for Continuing Education
Plantation, FL
Harvey C. Parker, Ph.D., CCMEP
National Association for Continuing Education
Plantation, FL
National Association for Continuing Education
Plantation, FL
Joshua Kilbridge, President
Kilbridge Associates
San Francisco, CA
Kilbridge Associates
San Francisco, CA
PROGRAM OVERVIEW:
Heart failure (HF) is a growing problem in the United States, affecting an estimated 5.1 million Americans ≥20 years of age. The disease is a cause for even greater concern among African Americans, in whom the relative incidence is 50% higher compared with the general population. Despite the availability of various treatment options, HF care is suboptimal in clinical practice. Provider barriers include knowledge barriers, diagnostic challenges, pharmacological concerns, communication issues, and personal factors. Early detection of HF can improve outcomes, but the symptoms and signs of HF are often difficult to identify because they are frequently confused with other disorders or are attributed to aging, obesity, or lack of conditioning. As a result, HF is misdiagnosed or underdiagnosed. HF patients may not receive any intervention or may be undertreated, resulting in a very small number of patients reaching goals and recommended levels of therapy with standard treatments including beta blockers, ACE inhibitors, ARBs, and diuretics.
After many years, new treatment options are available with novel mechanisms of action that can improve outcomes when added to optimized, guideline directed medical therapy. This program will raise awareness of risk factors for heart failure and the role of biomarkers, clarify the role that heart rate has in heart failure risk, help participants understand the indications for new therapies and demonstrate how to appropriately incorporate them into clinical practice.
This activity utilizes a flipped classroom design that begins with a foundational self-study followed by an online live webinar, which will be available on-demand after the live event, where all participants will have the opportunity to interact with the faculty and other learners.
DISCLOSURE POLICY STATEMENT:
It is the policy of ABC and NACE to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. NACE assesses conflict of interest with its faculty, planners and managers of CME activities. Conflicts of interest that are identified are resolved by reviewing that presenter's content for fair balance and absence of bias, scientific objectivity of studies utilized in this activity, and patient care recommendations.
DISCLOSURE OF CONFLICTS OF INTEREST:
Faculty
Barbara Hutchinson, MD, PhD, FACC has no real or apparent conflicts of interest to report.
Anekwe Onwuanyi, MD serves as a speaker for Novartis.
Planning Committee
Gregg Sherman, MD has no real or apparent conflicts of interest to report.
Harvey Parker, PhD has no real or apparent conflicts of interest to report.
Joshua Kilbridge has no real or apparent conflicts of interest to report.
DISCLOSURE OF UNLABELED USE:
ABC and NACE require that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
DISCLAIMER
The opinions expressed during the educational activity are those of the faculty and do not necessarily represent the views of ABC and NACE. The information is presented for the purpose of advancing the attendees' professional development.
ACCREDITATION STATEMENT:
The Association of Black Cardiologists is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The National Association for Continuing Education is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners. AANP Provider Number 121222.
This CME activity was planned and produced in accordance with the ACCME Essentials and the AANP CE Standards and Policies and AANP Commercial Support Standards.
For CME questions, please contact: NACE at info@naceonline.com.
Contact this CME provider for privacy and confidentiality policy statement information at: http://www.naceonline.com/privacy_policy.php.
CREDIT DESIGNATION STATEMENT:
The Association of Black Cardiologists designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim credit commensurate with the extent of their participation in the activity.
The National Association for Continuing Education has approved this program for 1.0 contact hour of continuing education (which includes 0.25 hours of pharmacology).
TO OBTAIN CME CREDITS:
- Read the learning objectives and faculty disclosures.
- Participate in the activity.
- Complete the post-test and activity evaluation.
- Physicians who successfully complete the post-test and evaluation will receive CME credit.
- Nurse Practitioners who successfully complete the post-test and evaluation will receive AANP CE credit.
- You must score 60% or higher on the post-test to receive credit for this activity.
- All other participants who successfully complete the post-test and evaluation will receive a certificate of participation.
COURSE FORMAT/MEDIUM: Internet CME Activity
ESTIMATED TIME TO COMPLETE: 60 minutes
ACKNOWLEDGEMENT:
This activity is provided by The Association of Black Cardiologists and The National Association for Continuing Education.
This activity is supported by educational funding provided by Amgen.
If you have any questions regarding this activity, send an email to info@naceonline.com.
Copyright © 2016 Association of Black Cardiologists and National Association for Continuing Education. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of ABC and NACE is prohibited.
COURSE VIEWING REQUIREMENTS
| Supported Browsers: Internet Explorer 9.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 Google Chrome 28.0+ for Windows, Mac OS, or Linux Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux Safari 6.0+ for Mac OSX 10.7 and above |
© 2007-2024 HealthCourse, Inc. All rights reserved.
